-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction: As we all know, COVID-19 mainly affects the respiratory tract of patients, causing serious damage
to the respiratory system of patients.
Recently, a paper published in the Journal of Alzheimer's Disease shows researchers a comprehensive review of the effects of COVID-19 on the nervous system, dividing the brain damage caused by COVID-19 into three stages
。 Dr.
"We understand that a large number of hospitalized COVID-19 patients have different degrees of brain function impairment
," Ferduch said.
SARS-Cov2: Mechanism of Cellular Action
.
In a recently published article, Foduch and his colleagues warn that people with COVID-19 suffer from neurological problems including stroke, epilepsy, confusion, vertigo, paralysis, and coma
.
The paper proposes the use of a three-stage "neurocoronavirus" classification system to provide a basis
for future hypotheses and investigations about SARS-CoV-2 and the nervous system.
· Neurocoronavirus Phase I: Viral damage is localized to the epithelial cells of the mouth and nose, and the main symptoms are transient loss
of smell and taste.
· Neurocoronavirus Phase II: The virus triggers inflammation and becomes a cytokine storm that starts in the lungs and spreads through blood vessels throughout the body
.
· Neurocoronavirus Phase III: Explosive levels of cytokine storms disrupt the blood-brain barrier (protective insulation layer in cerebral blood vessels
).
Ferduch noted that many people with COVID-19 may not have significant neurological symptoms at first; In some cases, however, patients may develop neurologic symptoms
between fever, cough, or shortness of breath.
"Our research on coronavirus shows that long-term patients may experience depression, insomnia, Parkinson's syndrome, memory loss or accelerated brain aging
," Fordushi explains.
These interventions, along with targeted brain training and neurofeedback therapy, are key features
of Dr.
Dr.